CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
to docetaxel in participants with advanced non-small cell lung cancer (NSCLC) harboring a KRAS G12C mutation who have been previous...
Phase 3
Budapest, Hungary and 50 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Budapest, Hungary and 210 other locations
Researchers are investigating new treatments for untreated advanced non-small cell lung cancer (NSCLC), which is the most common fo ...
Phase 2
Budapest, Hungary and 40 other locations
resectable, early-stage non-small cell lung cancer....
Phase 2
Törökbálint, Hungary and 95 other locations
purpose of this study is to evaluate how well Rina-S works against lung cancer.The treatment in this study is Rina-S monotherapy (b...
Phase 2
Tatabánya, Hungary and 40 other locations
In the SAMSON-2 study, the proposed biosimilar HD204 will be compared to its reference product EU-licensed Avastin®. The aim of the study is to demon...
Phase 3
Törökbálint, Hungary and 17 other locations
with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...
Phase 3
Budapest, Hungary and 262 other locations
growth factor A (VEGF-A) in participants with non-small cell lung cancer (NSCLC).The study will comprise several cohorts for dose ...
Phase 1
Budapest, Hungary and 44 other locations
The primary objective of this study is to evaluate the safety and tolerability of tarlatamab in combination with YL201 with or without anti-PD-L1.
Phase 1
Budapest, Hungary and 35 other locations
study was designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung...
Phase 3
Budapest, Hungary and 235 other locations
Clinical trials
Research sites
Resources
Legal